{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:37:42Z","timestamp":1771677462923,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.bone.2016.07.022","type":"journal-article","created":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T01:16:04Z","timestamp":1469841364000},"page":"148-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Atypical femur fracture in an adolescent boy treated with bisphosphonates for X-linked osteoporosis based on PLS3 mutation"],"prefix":"10.1016","volume":"91","author":[{"given":"Denise M.","family":"van de Laarschot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Carola","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bone.2016.07.022_bb0005","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1002\/jbmr.1719","article-title":"Incidence of atypical nontraumatic diaphyseal fractures of the femur","volume":"27","author":"Dell","year":"2012","journal-title":"J. Bone Miner. Res. [Internet]"},{"key":"10.1016\/j.bone.2016.07.022_bb0010","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005088.pub2","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","volume":"4","author":"Phillipi","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.bone.2016.07.022_bb0015","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/jbmr.2410","article-title":"Bisphosphonates for the prevention of fractures in osteogenesis imperfecta: meta-analysis of placebo-controlled trials","volume":"30","author":"Hald","year":"2015","journal-title":"J. Bone Miner. Res. [Internet]"},{"issue":"4","key":"10.1016\/j.bone.2016.07.022_bb0020","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.bone.2006.11.020","article-title":"Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta","volume":"40","author":"Rauch","year":"2007","journal-title":"Bone [Internet]"},{"issue":"8","key":"10.1016\/j.bone.2016.07.022_bb0025","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00198-007-0330-3","article-title":"Mughal MZ. Can bisphosphonate treatment be stopped in a growing child with skeletal fragility?","volume":"18","author":"Ward","year":"2007","journal-title":"Osteoporos. Int. [Internet]"},{"issue":"2","key":"10.1016\/j.bone.2016.07.022_bb0030","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1210\/jc.2008-1531","article-title":"Clinical review: bisphosphonate use in childhood osteoporosis","volume":"94","author":"Bachrach","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2016.07.022_bb0035","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11154-008-9074-4","article-title":"Osteogenesis Imperfecta: update on presentation and management","volume":"9","author":"Cheung","year":"2008","journal-title":"Rev. Endocr. Metab. Disord. [Internet]"},{"issue":"16","key":"10.1016\/j.bone.2016.07.022_bb0040","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMoa1308223","article-title":"PLS3 mutations in X-linked osteoporosis with fractures","volume":"369","author":"van Dijk","year":"2013","journal-title":"N. Engl. J. Med. [Internet]"},{"issue":"6","key":"10.1016\/j.bone.2016.07.022_bb0045","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","article-title":"Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment","volume":"164A","author":"Van Dijk","year":"2014","journal-title":"Am. J. Med. Genet. A [Internet]"},{"issue":"1","key":"10.1016\/j.bone.2016.07.022_bb0050","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Diaphyseal femoral fractures: second report of a task force of the american society for bone and mineral research","volume":"29","author":"Shane","year":"2014","journal-title":"J. Bone Miner. Res. [Internet]"},{"issue":"1","key":"10.1016\/j.bone.2016.07.022_bb0055","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11832-011-0380-0","article-title":"Changing pattern of femoral fractures in osteogenesis imperfecta with prolonged use of bisphosphonates","volume":"6","author":"Nicolaou","year":"2012","journal-title":"J. Child. Orthop."},{"issue":"3","key":"10.1016\/j.bone.2016.07.022_bb0060","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1210\/jc.2012-4195","article-title":"The paradox of prevention\u2014bilateral atypical subtrochanteric fractures due to bisphosphonates in osteogenesis imperfecta","volume":"98","author":"Manolopoulos","year":"2013","journal-title":"J. Clin. Endocrinol. Metab. [Internet]"},{"issue":"5","key":"10.1016\/j.bone.2016.07.022_bb0065","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3109\/17453674.2012.729183","article-title":"Atypical femoral fracture following bisphosphonate treatment in a woman with osteogenesis imperfecta\u2014a case report","volume":"83","author":"Meier","year":"2012","journal-title":"Acta Orthop."},{"issue":"00","key":"10.1016\/j.bone.2016.07.022_bb0070","first-page":"1","article-title":"Unusual femur stress fractures in children with osteogenesis imperfecta and intramedullary rods on long-term intravenous pamidronate therapy","volume":"00","author":"Hegazy","year":"2015","journal-title":"J. Pediatr. Orthop. [Internet]"},{"issue":"6","key":"10.1016\/j.bone.2016.07.022_bb0075","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/jbmr.308","article-title":"An atypical subtrochanteric femoral fracture from pycnodysostosis: a lesson from nature","volume":"26","author":"Yates","year":"2011","journal-title":"J. Bone Miner. Res. [Internet]"},{"issue":"8","key":"10.1016\/j.bone.2016.07.022_bb0080","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1007\/s11999-008-0256-x","article-title":"Case reports: treatment of subtrochanteric and ipsilateral femoral neck fractures in an adult with osteopetrosis","volume":"466","author":"Birmingham","year":"2008","journal-title":"Clin. Orthop. Relat. Res. [Internet]"},{"issue":"3","key":"10.1016\/j.bone.2016.07.022_bb0085","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1210\/jc.2009-1965","article-title":"Lack of sustained response to teriparatide in a patient with adult hypophosphatasia","volume":"95","author":"Gagnon","year":"2010","journal-title":"J. Clin. Endocrinol Metab. [Internet]"},{"issue":"6","key":"10.1016\/j.bone.2016.07.022_bb0090","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1359\/jbmr.081253","article-title":"Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia","volume":"24","author":"Whyte","year":"2009","journal-title":"J. Bone Miner. Res. [Internet]"},{"key":"10.1016\/j.bone.2016.07.022_bb0095","first-page":"247","article-title":"Pycnodysostosis presenting with bilateral subtrachanteric fractures: case report","volume":"117","author":"Roth","year":"1976","journal-title":"Clin. Orthop. Relat. Res. [Internet]"},{"issue":"3","key":"10.1016\/j.bone.2016.07.022_bb0100","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00402-006-0270-y","article-title":"Surgical outcomes after treatment of fractures in femur and tibia in pycnodysostosis","volume":"127","author":"Nakase","year":"2007","journal-title":"Arch. Orthop. Trauma Surg. [Internet]"},{"issue":"2","key":"10.1016\/j.bone.2016.07.022_bb0105","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S1297-319X(03)00143-X","article-title":"Subtrochanteric fracture managed by intramedullary nail in a patient with pycnodysostosis","volume":"71","author":"Kundu","year":"2004","journal-title":"Joint Bone Spine [Internet]"},{"issue":"3","key":"10.1016\/j.bone.2016.07.022_bb0110","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J. Clin. Endocrinol. Metab. [Internet]"},{"issue":"2","key":"10.1016\/j.bone.2016.07.022_bb0115","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.bone.2013.07.012","article-title":"Atypical fracture of the tibial diaphysis associated with bisphosphonate therapy: a case report","volume":"56","author":"Bissonnette","year":"2013","journal-title":"Bone [Internet]"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328216302101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328216302101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:53:36Z","timestamp":1536540816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328216302101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":23,"alternative-id":["S8756328216302101"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2016.07.022","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical femur fracture in an adolescent boy treated with bisphosphonates for X-linked osteoporosis based on PLS3 mutation","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2016.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}